Emerging Strategies for Cardio-Renal Protection Beyond RAAS Blockade: Emphasis on Non-diabetic CKD and Resistant Hypertension
Saudi Medical Journal · 2026
DOI: 10.15537/1658-3175.8819 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Saudi Medical Journal, 2026. Verfasst von Fahad S Alrashidi. Beteiligte Einrichtung: Consultant, Internal Medicine/Nephrology, Department of Medicine (Nephrology), Ad-Diriyah Hospital, Riyadh, Kingdom of Saudi Arabia. Hauptthemen laut MEDLINE: Hypertension, Renal Insufficiency, Chronic, Renin-Angiotensin System. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Non-diabetic chronic kidney disease (ND-CKD) complicated by resistant hypertension remains a high-risk phenotype even when renin–angiotensin system blockade is optimized. This review synthesizes contemporary evidence for cardio-renal protection beyond traditional renin-angiotensin-aldosterone system inhibition (RAASi), with emphasis on mechanisms, clinical trial data, and pragmatic sequencing. Sodium–glucose cotransporter 2 inhibitors provide hemodynamic and tubular benefits that translate into renal and heart failure risk reduction in many patients with ND-CKD. Non-steroidal mineralocorticoid receptor antagonism (MRA) like finerenone targets inflammatory and fibrotic signaling and may add incremental benefit when potassium is proactively managed. The GLP-1 receptor agonists offer cardiometabolic advantages with emerging kidney signals, particularly in patients with obesity and high cardiovascular risk. Modern potassium binders can preserve RAASi/MRA intensity, and device-based blood pressure strategies (including renal denervation) may be considered in carefully selected resistant hypertension. We propose a stepwise implementation framework to maximize efficacy while minimizing adverse events through structured monitoring and multidisciplinary care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Consultant, Internal Medicine/Nephrology, Department of Medicine (Nephrology), Ad-Diriyah Hospital, Riyadh, Kingdom of Saudi Arabia.
ORCID-Profile: Fahad S Alrashidi
Zitieren
APA
Alrashidi, F. S. (2026). Emerging Strategies for Cardio-Renal Protection Beyond RAAS Blockade: Emphasis on Non-diabetic CKD and Resistant Hypertension. Saudi Medical Journal. https://doi.org/10.15537/1658-3175.8819
Vancouver
Alrashidi FS. Emerging Strategies for Cardio-Renal Protection Beyond RAAS Blockade: Emphasis on Non-diabetic CKD and Resistant Hypertension. Saudi Medical Journal. 2026. doi:10.15537/1658-3175.8819
BibTeX
@article{Alrashidi2026,
author = {Alrashidi, Fahad S},
title = {Emerging Strategies for Cardio-Renal Protection Beyond RAAS Blockade: Emphasis on Non-diabetic CKD and Resistant Hypertension},
journal = {Saudi Medical Journal},
year = {2026},
doi = {10.15537/1658-3175.8819}
}
EUVIMED